VPHM: Analysis & Opinions

  1. Data on ViroPharma's Cinryze - Analyst Blog

    January 18, 2013
    ViroPharma (VPHM) recently announced that The Journal of Pediatrics published data in an article on Jan 14, 2013, ...
  2. MDCO Scores in SOLO-1 Trial - Analyst Blog

    December 24, 2012
    The Medicines Company (MDCO) recently received good news with the company announcing positive results on its phase ...
  3. Fresenius Medical Care AG & Co and More Big Movers in ...

    November 27, 2012
    The market is currently down, with the Nasdaq declining 0.2%, the S&P 500 slipping 0.2% and the Dow down 0.3%. The ...
  4. ViroPharma Presents Cinryze Data - Analyst Blog

    November 14, 2012
    ViroPharma Inc. (VPHM) presented promising data on Cinryze at the American College of Allergy, Asthma and ...
  5. Watson Beats, Revises Outlook - Analyst Blog

    November 01, 2012
    Watson Pharmaceuticals Inc.'s (WPI) third quarter 2012 earnings (excluding special items) of $1.35 per share ...
  6. Revenues Fall at ViroPharma - Analyst Blog

    October 29, 2012
    ViroPharma Inc.'s (VPHM) third quarter 2012 adjusted earnings (including stock based compensation) of 3 cents per ...
  7. Pertaining to Relief for ViroPharma - Analyst Blog

    September 25, 2012
    The US Food and Drug Administration (FDA) recently informed ViroPharma Incorporated (VPHM) that the company may ...
  8. Questcor Pharmaceuticals Among Healthcare's Biggest ...

    September 21, 2012
    Currently, the Nasdaq has moved little, the S&P 500 is trading down 0.3% and the Dow has remained steady. The ...
  9. Abbott-Astellas Collaborate - Analyst Blog

    September 13, 2012
    Abbott Laboratories (ABT) recently announced that it is collaborating with Astellas Pharma Global Development for a ...
  10. Eli Lilly Among Healthcare's Biggest Movers on August ...

    August 27, 2012
    The market is on the rise this morning. The Nasdaq is up 0.5%; the S&P 500 has risen 0.3%; and the Dow has climbed ...
  11. CareFusion Corporation and More Big Movers in Healthcare ...

    August 10, 2012
    The morning has been bad for the market. The Nasdaq is trading down 0.2%; the S&P 500 is down 0.2%; and the Dow has ...
  12. ViroPharma Misses Zacks Estimates - Analyst Blog

    August 10, 2012
    ViroPharma Inc.'s (VPHM) second quarter 2012 adjusted earnings of 2 cents per share was well short of the Zacks ...
  13. VPHM Manufacturing Process Approved - Analyst Blog

    August 07, 2012
    The US Food and Drug Administration (FDA) recently approved ViroPharma Incorporated's (VPHM) supplement to the ...
  14. Bad News for ViroPharma - Analyst Blog

    August 03, 2012
    ViroPharma Incorporated (VPHM) recently announced that the US Food and Drug Administration (FDA) has advised the ...
  15. Cubist Initiates Patient Enrolment - Analyst Blog

    July 13, 2012
    Cubist Pharmaceuticals, Inc. (CBST) recently announced the first enrolment in one of two identical, global phase III ...
  16. ViroPharma Falters, Guides Lower - Analyst Blog

    May 02, 2012
    ViroPharma Falters, Guides Lower - Analyst Blog
  17. 6 Overbought Stocks To Watch

    December 19, 2011
    Let's take a look at a few stocks that have recently entered overbought territory because these could be candidates ...
  18. 4 Stocks At 52-Week Highs

    November 24, 2011
    Four stocks tjat are hitting highs in their 52-week trading ranges and could cause many investors to take a closer look.
  19. Four Stocks That Are Actually Going Up

    July 11, 2008
    When all other methods fail, maybe the best solution is just looking for stocks that are rising. We examine a ...
  20. Biotech's Best And Worst

    April 14, 2008
    Not all biotech stocks are built the same. Now could be the time to make exits on the winners and go bargain hunting.
Marketplace
Trading Center